Description
Springer Innovation of Diagnosis and Treatment for Pancreatic Cancer 1st Editon 2018 Softbound by Hiroki Yamaue
This collection of chapters describes in detail the latest insights into the evaluation of resectability and neoadjuvant therapy to pancreaticoduodenectomy and distal pancreatectomy for pancreatic cancer. Shedding light on immunotherapy and gene therapy, this volume comprehensively covers treatments and procedures for the disease, allowing surgeons and trainees to gain an overview and explore innovative treatments. It also provides information on various cases using tools such as endoscopic ultrasound, MDCT, PET for diagnosis and laparoscopy and robotic resection methods. Edited and authored by pioneering professionals, Diagnosis and Treatment for Pancreatic Cancer is a valuable resource for gastroenterologists, medical oncologists, surgical oncologist and general surgeons interested in treatment of pancreatic cancer care.
1_Early diagnosis of pancreatic cancer using endoscopic ultrasound 2_Evaluation of resectability for pancreatic cancer using endoscopic ultrasound 3_Evaluation of resectability of pancreatic cancer by multidetector row Computed Tomography (MDCT) 4_Evaluation of Effect of Neoadjuvant Therapy using Positron Emission Tomography 5_Liquid biopsy for early detection of pancreatic cancer 6_Pancreaticoduodenectomy ‐ standard resection and extended resection 7_Pylorus-Resecting Pancreaticoduodenectomy 8_Pancreaticoduodenectomy with Portal Vein Resection 9_Pancreatoduodenectomy with Concomitant Vascular Resection for Pancreas Cancer 10_Laparoscopic Pancreaticoduodenectomy 11_Robotic Pancreaticoduodenectomy: Technical Approaches and Outcomes 12_Distal Pancreatectomy for Pancreatic Carcinoma 13_Distal pancreatectomy with en bloc celiac axis resection (DP-CAR) for advanced pancreatic carcinoma 14_Indications and Pitfalls of the Modified Distal Pancreatectomy with Celiac Axis en-bloc Resection for Pancreatic Cancer 15_Laparoscopic Distal Pancreatectomy for Pancreatic Cancer 16_Development of Cancer Vaccine and Targeted Immune Checkpoint Therapies 17_Development of Hypoxia‐activated, cytotoxic prodrug 18_The Potential of Oncolytic Virus Therapy for Pancreatic Cancer